Unicorn Nest Logo

HT Capital

htcapital.org
Total investments

19

Average round size

26M

Portfolio companies

15

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsManufacturingMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Investments analytics

Analytics

Total investments
19
Lead investments
0
Investments by industry
  • Biotechnology (10)
  • Health Care (7)
  • Medical Device (3)
  • Biopharma (3)
  • Medical (2)
    • Show 22 more
Investments by region
  • United States (9)
  • China (2)
  • Japan (2)
  • Israel (2)
  • Taiwan (1)
Peak activity year
2018
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
106M
Group Appearance index
0.89

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
EquipmentShare24 Jan 2017Rental, Construction, Service Industry, Fleet ManagementEarly Stage Venture26MUnited States, Missouri, Columbia
Kula Bio03 Jan 2022Biotechnology, Food and Beverage, Agriculture, FarmingEarly Stage Venture50MUnited States, Massachusetts
25 Oct 2018Biotechnology, Artificial Intelligence, PharmaceuticalEarly Stage Venture46MUnited States, Cambridge
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.